Thyroid Eye Disease

被引:12
作者
Cockerham, Kimberly P. [1 ]
Chan, Stephanie S. [1 ]
机构
[1] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA
关键词
Graves disease; Thyroid eye disease; Thyroid-associated ophthalmopathy; Compressive optic neuropathy; QUALITY-OF-LIFE; METHYLPREDNISOLONE PULSE THERAPY; HUMAN ORBITAL FIBROBLASTS; ENDOPEROXIDE H SYNTHASE-2; FACTOR-I RECEPTOR; HUMAN RETROOCULAR FIBROBLASTS; VISUAL FUNCTION QUESTIONNAIRE; OPHTHALMIC GRAVES-DISEASE; T2; RELAXATION-TIME; MAGNETIC-RESONANCE;
D O I
10.1016/j.ncl.2010.03.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Thyroid eye disease (TED) is the most common cause of proptosis in adults, and should always be a consideration in patients with unexplained diplopia, pain, or optic nerve dysfunction At least 80% of TED is associated with Graves disease (GD), and at least 50% of patients with GD develop clinically evident symptomatic TED. The most confusing patients for doctors of all subspecialties are the patients with eye symptoms and signs that precede serum evidence of a thyroid imbalance. Management of TED may include immunosuppressive medications, radiation, or surgery. Although the prognosis for optic nerve function is excellent, the restrictive dysmotility can result in permanent disability. Orbit and eyelid reconstruction are reserved for stable, inactive patients and are the final steps in minimizing facial alterations and enhancing the patient's daily functioning.
引用
收藏
页码:729 / +
页数:28
相关论文
共 192 条
[1]   Structure and function of the type 1 insulin-like growth factor receptor [J].
Adams, TE ;
Epa, VC ;
Garrett, TPJ ;
Ward, CW .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (07) :1050-1093
[2]  
Ainbinder DJ, 2003, OPHTHALMOLOGY, V110, P449, DOI 10.1016/S0161-6420(02)01840-7
[3]   Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy [J].
Aniszewski, JP ;
Valyasevi, RW ;
Bahn, RS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :776-780
[4]   THE FIBROBLAST IS THE TARGET-CELL IN THE CONNECTIVE-TISSUE MANIFESTATIONS OF GRAVES-DISEASE [J].
BAHN, RS .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 106 (03) :213-218
[5]   Pathophysiology of Graves' ophthalmopathy: The cycle of disease [J].
Bahn, RS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05) :1939-1946
[6]   HUMAN RETROOCULAR FIBROBLASTS INVITRO - A MODEL FOR THE STUDY OF GRAVES OPHTHALMOPATHY [J].
BAHN, RS ;
GORMAN, CA ;
WOLOSCHAK, GE ;
DAVID, CS ;
JOHNSON, PM ;
JOHNSON, CM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (04) :665-670
[7]   RETROOCULAR FIBROBLASTS - IMPORTANT EFFECTOR-CELLS IN GRAVES OPHTHALMOPATHY [J].
BAHN, RS ;
HEUFELDER, AE .
THYROID, 1992, 2 (01) :89-94
[8]  
Balcer LJ, 2005, NEUROLOGY, V64, pA37
[9]   Management of Graves' ophthalmopathy: Reality and perspectives [J].
Bartalena, L ;
Pinchera, A ;
Marcocci, C .
ENDOCRINE REVIEWS, 2000, 21 (02) :168-199
[10]   ORBITAL COBALT IRRADIATION COMBINED WITH SYSTEMIC CORTICOSTEROIDS FOR GRAVES OPHTHALMOPATHY - COMPARISON WITH SYSTEMIC CORTICOSTEROIDS ALONE [J].
BARTALENA, L ;
MARCOCCI, C ;
CHIOVATO, L ;
LADDAGA, M ;
LEPRI, G ;
ANDREANI, D ;
CAVALLACCI, G ;
BASCHIERI, L ;
PINCHERA, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (06) :1139-1144